138 related articles for article (PubMed ID: 23448994)
1. Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia.
Correia NC; Durinck K; Leite AP; Ongenaert M; Rondou P; Speleman F; Enguita FJ; Barata JT
Leukemia; 2013 Jul; 27(7):1603-6. PubMed ID: 23448994
[No Abstract] [Full Text] [Related]
2. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
3. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
Cho HS; Kim MK; Bae YK
Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
[TBL] [Abstract][Full Text] [Related]
4. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
[No Abstract] [Full Text] [Related]
6. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
7. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
8. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
9. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
10. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
11. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
[No Abstract] [Full Text] [Related]
12. [How a suppressor of tumor gets hooked of the leukaemic proliferation in man].
Pflumio F; Kusy S; Gerby B; Roméo PH
Med Sci (Paris); 2011 Feb; 27(2):142-3. PubMed ID: 21382322
[No Abstract] [Full Text] [Related]
13. Cancer. Cancer by super-enhancer.
Vähärautio A; Taipale J
Science; 2014 Dec; 346(6215):1291-2. PubMed ID: 25504702
[No Abstract] [Full Text] [Related]
14. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.
Mets E; Van der Meulen J; Van Peer G; Boice M; Mestdagh P; Van de Walle I; Lammens T; Goossens S; De Moerloose B; Benoit Y; Van Roy N; Clappier E; Poppe B; Vandesompele J; Wendel HG; Taghon T; Rondou P; Soulier J; Van Vlierberghe P; Speleman F
Leukemia; 2015 Apr; 29(4):798-806. PubMed ID: 25231743
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
17. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
18. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
19. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
[TBL] [Abstract][Full Text] [Related]
20. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
